News Category
NanoViricides is set to begin a Phase II clinical trial of its oral antiviral NV-387 for Ebola in the Democratic Republic of Congo, potentially offeri...
GeoVax highlights its MVA-based vaccine candidates and expertise as the Bundibugyo Ebola outbreak in Congo becomes the fastest-growing on record, posi...
NanoViricides' regulatory approval to test its oral antiviral NV-387 in a Phase II Ebola trial in the DRC marks a potential shift toward more accessib...
NanoViricides has submitted an application to begin a Phase II trial of NV-387 Oral Gummies for Bundibugyo ebolavirus in the DRC, where no approved tr...
NanoViricides has applied to the DRC regulatory agency to begin a Phase II trial of its oral antiviral NV-387 against the Bundibugyo ebolavirus, aimin...
NanoViricides gains ethics committee approval in the DRC for a Phase II trial of NV-387 oral gummies against ebolavirus, potentially offering the firs...
Despite unrest in the Middle East disrupting key mining inputs, the Democratic Republic of Congo's copper and cobalt production remains unaffected, of...
NanoViricides is progressing its oral gummies formulation of NV-387 toward a Phase II trial for the Bundibugyo ebolavirus outbreak in the DRC, where n...
NanoViricides has shipped its broad-spectrum antiviral NV-387 to the Democratic Republic of Congo for a Phase II trial against MPox, with implications...
NanoViricides has received approval from the Democratic Republic of Congo's Pillar Committee to conduct a Phase II clinical trial of its oral antivira...
Redwood AI Corp. has signed a letter of intent to collaborate on a regional pathogen tracking and AI-driven outbreak intelligence initiative in Centra...
Trident Digital Tech Holdings Ltd. announced the launch of TDTHAI, an AI platform for enterprise deployment, workflow automation, and digital transfor...
The U.S. CDC has extended its travel ban to legal permanent residents who have been in Uganda, South Sudan, or the DRC within the past 21 days to prev...
NanoViricides announces that its broad-spectrum antiviral NV-387 may be evaluated for treating the Bundibugyo Ebola outbreak, citing its host-targeted...
NanoViricides, Inc. emphasized the potential of its oral drug candidate NV-387 as a pandemic preparedness tool for Ebola and related viral threats, ci...
NanoViricides reported progress in its quarterly filing, highlighting regulatory approval for Phase II MPox trials in the DRC and FDA orphan drug desi...
The ongoing conflict in Iran is straining the supply of critical processing chemicals for cobalt and copper miners in the Democratic Republic of Congo...
NanoViricides announced a Phase II clinical trial of its antiviral candidate NV-387 for MPox in the DRC, highlighting progress in addressing Clade I M...
Virtus Minerals, a US-based critical minerals firm, will acquire Chemaf, a DRC miner of lithium and cobalt, highlighting growing US interest in securi...
Easy Environmental Solutions leverages its Terreplenish® microbial solution to address the worldwide nitrogen shortage caused by Middle East turmoil, ...
NanoViricides announces completion of NV-387 Oral Gummies drug product manufacturing and will present progress at NIBA's 152nd Investment Conference, ...
The Democratic Republic of Congo has resumed cobalt exports after a 10-month ban, underscoring global market fragility due to concentrated supply and ...
Micropolis AI Robotics signed a $9.3 million agreement with AfricAI to design three unmanned ground vehicles and secure exclusive distribution across ...
NanoViricides President Dr. Anil Diwan discussed the company's nanoviricide platform and lead candidate NV-387, which has shown efficacy against multi...
The Democratic Republic of Congo's suspension of cobalt exports and shift to a quota system threatens a supply deficit by 2026, potentially driving up...
Sekur Private Data Ltd. attends the Africa Digital Innovation Summit to expand its secure communications solutions in the Democratic Republic of Congo...
A temporary bridge collapse at a cobalt and copper mine in the Democratic Republic of Congo resulted in at least 32 deaths, highlighting the critical ...
NanoViricides announced regulatory approval from the DRC to start a Phase II trial of NV-387 for MPox, a broad-spectrum antiviral that could transform...
A series of production disruptions at major mines in Congo, Chile, and Indonesia have driven copper prices to their highest in 17 months, prompting an...
NanoViricides (NYSE American: NNVC) was featured in a Proactive Investors analyst report detailing its dual-track clinical development strategy for NV...
